Lemaitre Vascular (LMAT) Current Leases (2019 - 2026)
Lemaitre Vascular's (LMAT) quarterly Current Leases came in at $3.4 million in Q2 2026, up 21.56% year-over-year from $2.8 million in Q2 2025, and little changed quarter-over-quarter from $3.4 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Current Leases (2019 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Current Leases for 8 consecutive years, with $3.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Leases rose 21.56% year-over-year to $3.4 million in Q2 2026; TTM through Jun 2026 was $3.4 million, a 21.56% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 9.81% from the prior year.
- Current Leases was $3.4 million for Q2 2026 at Lemaitre Vascular, roughly flat from $3.4 million in the prior quarter.
- Over five years, Current Leases peaked at $3.4 million in Q1 2026 and troughed at $1.8 million in Q2 2022.
- A 5-year average of $2.5 million and a median of $2.6 million in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases retreated 8.19% in 2022 and surged 50.38% in 2023, its largest moves.
- Over 5 years, Current Leases stood at $1.9 million in 2022, then soared by 31.02% to $2.5 million in 2023, then advanced by 8.5% to $2.7 million in 2024, then increased by 9.81% to $2.9 million in 2025, then grew by 16.81% to $3.4 million in 2026.
- The last three Current Leases figures came in at $3.4 million (Q2 2026), $3.4 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 24.10 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 81.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 20.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 3.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.44 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.72 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | 2.47 Mn |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.87 Mn |
| Dec 31, 2021 | 1.87 Mn |
| Sep 30, 2021 | 1.90 Mn |